Volitionrx Ltd (VNRX): Total Assets

Annual figures by period end, from SEC filings.

$6.90M
As of 2025-12-31
$8.30M
As of 2026-06-30
-27.7%
3-year compound annual growth
-23.4%
5-year compound annual growth
-1.1%
10-year compound annual growth
$27.95M2011-12-31: $2.25M2012-12-31: $2.22M2013-12-31: $2.07M2014-12-31: $3.43M2015-12-31: $7.71M2016-12-31: $24.73M2017-12-31: $14.62M2018-12-31: $17.49M2019-12-31: $21.29M2020-12-31: $26.15M2021-12-31: $27.49M2022-12-31: $18.30M2023-12-31: $27.95M2024-12-31: $9.40M2025-12-31: $6.90M$6.90M
2011-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$6.90M-26.6%2026-03-31, Balance as of period end
2024-12-31$9.40M-66.4%2026-03-31, Balance as of period end
2023-12-31$27.95M+52.8%2025-03-31, Balance as of period end
2022-12-31$18.30M-33.4%2024-03-25, Balance as of period end
2021-12-31$27.49M+5.1%2023-03-15, Balance as of period end
2020-12-31$26.15M+22.8%2022-03-30, Balance as of period end
2019-12-31$21.29M+21.7%2021-03-22, Balance as of period end
2018-12-31$17.49M+19.6%2020-02-20, Balance as of period end
2017-12-31$14.62M-40.9%2019-03-13, Balance as of period end
2016-12-31$24.73M+220.7%2018-03-01, Balance as of period end
2015-12-31$7.71M+124.6%2017-03-10, Balance as of period end
2014-12-31$3.43M+65.8%2016-03-11, Balance as of period end
2013-12-31$2.07M-6.6%2015-03-18, Balance as of period end
2012-12-31$2.22M-1.3%2014-03-28, Balance as of period end
2011-12-31$2.25Mn/a2013-04-01, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Volitionrx Ltd (VNRX)2025-12-31$6.90M-26.6%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$582.98M-26.4%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$25.76M-26.6%
Biomerica Inc (BMRA)2026-05-31$6.76M+13.7%
Anbio Biotechnology (NNNN)2025-12-31$30.24M+59.8%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.46M-0.6%
Immucell Corp (ICCC)2025-12-31$42.53M-5.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$103.58M-12.8%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$842.13M-29.3%

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗